Your account is not claimed yet. You can sign up with ORCID to claim your account.

Ilaria Crespiatico

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Viruses

Cancers

Clinical case reports

University of Milano-Bicocca

University of Milano-Bicocca (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Milano-Bicocca Apr 15o 2019

Italy

Scholarship :: School of Medicine and Surgery

Education History

University of Milano-Bicocca - Mar 21o 2019

Italy

MSC :: School of Medicine and Surgery

Publications

Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Giulia Arosio, Geeta Geeta Sharma, Matteo Villa, Mario Mauri, Ilaria Crespiatico, Diletta Fontana, Chiara Manfroni, Cristina Mastini, Marina Zappa, Vera Magistroni, Monica Ceccon, Sara Redaelli, Luca Massimino, Anna Garbin, Federica Lovisa, Lara Mussolin, Rocco Giovanni Piazza, Carlo Gambacorti-Passerini, Luca Mologni
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers 13 (17) (2021)
Ilaria Crespiatico, Elisa Bossi, Filippo Brioschi, Rocco Piazza, Luca Mologni, Carlo Gambacorti-Passerini
An Imatinib-non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization. Clinical case reports 8 (1) (2019)

Ilaria Crespiatico.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ilaria Crespiatico